ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,808Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 151

$684K Total Retail Price of All Prescriptions

Rank: 31 out of 151

735 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 735 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 735 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 9,514 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 501 460 1 1
AMLODIPINE BESYLATE 343 329 2 3
LEVOTHYROXINE SODIUM 328 327 3 2
OMEPRAZOLE 306 303 4 4
LISINOPRIL 300 262 5 5
HYDROCODONE-ACETAMINOPHEN 283 225 S3 6 10
ATORVASTATIN CALCIUM 249 230 7 16
ZOLPIDEM TARTRATE 233 189 8 17
PRAVASTATIN SODIUM 228 214 9 23
ATENOLOL 227 195 10 11
FUROSEMIDE 199 175 11 6
CITALOPRAM HBR 177 164 12 18
METFORMIN HCL 174 151 13 8
TRAMADOL HCL 173 99 14 24
MELOXICAM 167 164 15 57
METOPROLOL TARTRATE 160 141 16 7
GABAPENTIN 137 128 17 14
DONEPEZIL HCL 136 136 18 15
TERAZOSIN HCL 129 113 19 99
ALENDRONATE SODIUM 117 116 20 26
GLIMEPIRIDE 112 101 21 58
METOPROLOL SUCCINATE 109 106 22 21
CRESTOR 107 90 23 27
BENAZEPRIL HCL 99 97 24 103
OXYCODONE HCL 93 12 S2 25 67
HYDROCHLOROTHIAZIDE 91 81 26 13
WARFARIN SODIUM 88 86 27 9
TRAZODONE HCL 85 59 28 48
LOSARTAN POTASSIUM 80 76 29 12
ALLOPURINOL 77 70 30 42
CIPROFLOXACIN HCL 76 70 31 51
CELEBREX 75 72 32 110
CYCLOBENZAPRINE HCL 75 60 R 32 126
NEXIUM 75 64 32 44
TAMSULOSIN HCL 74 70 35 30
CARVEDILOL 74 73 35 22
FENOFIBRATE 71 71 37 61
BACLOFEN 71 51 37 87
LOSARTAN-HYDROCHLOROTHIAZIDE 68 68 39 59
FLUTICASONE PROPIONATE 65 60 40 35
FINASTERIDE 65 63 40 70
CARISOPRODOL 65 14 R 40 141
CLOPIDOGREL 65 50 40 29
DICLOFENAC SODIUM 63 57 44 109
TRIAMTERENE-HCTZ 60 54 45 68
PREDNISONE 58 53 46 45
RAMIPRIL 56 55 47 88
IBUPROFEN 52 46 48 69
LEVEMIR FLEXPEN 52 52 48 339
OXYCODONE-ACETAMINOPHEN 52 48 S2 48 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 6, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.